Guidance for Phibro Animal Health (PAHC)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $1.46B – 1.50B | $1.49B | = Maintained | Details |
| 2026 | $2.93 – $3.10 | $3.02 | $1.45B – 1.50B | $1.51B | = Maintained | Details |
| 2026 | $2.64 – $2.81 | $2.63 | $1.43B – 1.48B | $1.46B | = Maintained | Details |
| 2025 | $1.96 – $2.09 | $1.94 | $1.26B – 1.29B | $1.28B | = Maintained | Details |
| 2025 | $1.34 – $1.48 | $1.63 | $1.05B – 1.10B | $1.37B | = Maintained | Details |
| 2025 | $1.22 – $1.37 | $1.24 | $1.04B – 1.09B | $1.03B | = Maintained | Details |
| Q3 2025 | $1.87 – $2.01 | $1.71 | $1.25B – 1.30B | $1.32B | = Maintained | Details |
| 2024 | $1.04 – $1.16 | N/A | $980.00B – 1.02B | N/A | = Maintained | Details |
| 2024 | $1.04 – $1.16 | $1.07 | $980.00M – 1020.00M | $988.10M | = Maintained | Details |
| 2024 | $1.04 – $1.16 | $1.18 | $0.98B – 1.02B | $1.02B | = Maintained | Details |
| 2023 | $1.21 – $1.31 | $1.27 | $0.96B – 1.00B | $0.98B | = Maintained | Details |
| 2023 | N/A | N/A | $960.00M – 1000.00M | $910.21M | Raised |
Details |
| 2022 | $1.30 – $1.39 | $1.36 | $930.00M – 950.00M | $907.50M | = Maintained | Details |
| 2022 | N/A | N/A | $890.00M – 920.00M | $879.00M | = Maintained | Details |
| 2022 | $1.25 – $1.32 | $1.26 | $840.00M – 870.00M | $827.20M | = Maintained | Details |
| 2021 | $1.20 – $1.22 | $1.21 | $826.10M – 830.10M | $805.90M | = Maintained | Details |
| Q4 2021 | $0.30 – $0.32 | $0.28 | $213.00M – 217.00M | $200.00M | = Maintained | Details |
| Q2 2021 | $0.30 – $0.33 | $0.33 | $205.00M – 208.00M | $212.68M | = Maintained | Details |
| Q1 2021 | $0.18 – $0.20 | $0.26 | $190.00M | $189.49M | = Maintained | Details |
| 2020 | $1.08 – $1.15 | $1.66 | $833.00M – 863.00M | $858.12M | = Maintained | Details |
| 2019 | $1.50 – $1.55 | $1.68 | $828.00M – 833.00M | $854.20M | = Maintained | Details |
| 2019 | $1.68 – $1.72 | $1.75 | N/A | N/A | = Maintained | Details |
| 2018 | $1.55 – $1.61 | $1.54 | $765.00M – 790.00M | $779.05M | = Maintained | Details |
| Q4 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2017 | $1.44 – $1.47 | $1.43 | $760.00M – 765.00M | $757.00M | = Maintained | Details |
| 2017 | $1.38 – $1.45 | $1.63 | $750.00M – 770.00M | $768.00M | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $1.58 – $1.60 | $1.70 | $745.00M – 750.00M | $775.00M | Lowered |
Details |
| 2016 | $1.65 – $1.75 | $1.77 | $780.00M – 800.00M | $792.30M | = Maintained | Details |
| 2015 | $1.65 – $1.67 | $1.62 | $749.00M – 754.00M | $760.50M | = Maintained | Details |
| 2015 | $1.46 – $1.51 | N/A | $735.00M – 755.00M | N/A | = Maintained | Details |
| 2014 | $1.57 – $1.62 | $1.49 | $739.00M – 759.00M | $742.00M | = Maintained | Details |
| 2014 | $1.19 – $1.22 | N/A | $682.00M – 685.00M | N/A | = Maintained | Details |
| Q4 2014 | $0.21 – $0.24 | N/A | $174.00M – 177.00M | N/A | = Maintained | Details |


Raised
Lowered